Stryker set aside $1.5billion dollars for compensation for people injured with the Rejuvenate and ABGII metal-on-metal modular hip implants.
With these implants when the hips metal components rub together in movement they create minute metallic debris that can enter the patient’s bloodstream and severely damage tissue and muscle. In addition to metallic debris in the blood stream, recipients of the metal-on-metal hips have reported a variety of complications including pain, loosening of the joint, hip dislocation, difficulty walking and cysts around the joint. Thousands of patients have filed lawsuits over such injuries and complications.
Liam Moloney of Moloney & Co Solicitors in Dublin has filed many claims on behalf of Irish patients injured when they received the DePuy ASR hip device. These cases are currently being settled. Unlike the Stryker settlement programme no such settlement programme was established by DePuy in Ireland therefore law firms representing patients have to issue High Court proceedings in each and every case. To date DePuy have not admitted liability in any case in Ireland. Stryker recalled the ABGII and rejuvenate modular hip systems in June 2012 because of the high early failure rate of the hips and the risk of metallosis. In November 2014 Stryker announced a settlement programme for patients who had received one of the re-called hip devices. Patients who had one hip implanted and removed prior to November 3rd 2014 are eligible for $300,000 base compensation. Patients who had both hips implanted and removed will receive $600,000.
If this issue affects you please contact our firm today in the strictest of confidence for advice concerning your rights to compensation.
